196 related articles for article (PubMed ID: 32361381)
1. Limited added value of contrast-enhanced ultrasound over B-mode for the subtyping of hepatocellular adenomas.
Gregory J; Paisant A; Paulatto L; Raynaud L; Bertin C; Kerbaol A; Vullierme MP; Paradis V; Vilgrain V; Ronot M
Eur J Radiol; 2020 Jul; 128():109027. PubMed ID: 32361381
[TBL] [Abstract][Full Text] [Related]
2. Analysis of contrast-enhanced ultrasound features of hepatocellular adenoma according to different pathological molecular classifications.
Chen K; Dong Y; Zhang W; Han H; Mao F; Zhang Q; Zheng Z; He W; Wang WP
Clin Hemorheol Microcirc; 2020; 76(3):391-403. PubMed ID: 32675402
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience.
Garcovich M; Faccia M; Meloni F; Bertolini E; de Sio I; Calabria G; Francica G; Vidili G; Riccardi L; Zocco MA; Ainora ME; Ponziani FR; De Gaetano AM; Gasbarrini A; Rapaccini GL; Pompili M
J Ultrasound; 2019 Jun; 22(2):157-165. PubMed ID: 30306412
[TBL] [Abstract][Full Text] [Related]
4. Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings.
Laumonier H; Cailliez H; Balabaud C; Possenti L; Zucman-Rossi J; Bioulac-Sage P; Trillaud H
AJR Am J Roentgenol; 2012 Aug; 199(2):341-8. PubMed ID: 22826395
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound features of hepatocellular adenoma and the additional value of contrast-enhanced ultrasound.
Dong Y; Zhu Z; Wang WP; Mao F; Ji ZB
Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):48-54. PubMed ID: 26818543
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma.
Kong WT; Wang WP; Huang BJ; Ding H; Mao F; Si Q
Ultrasound Med Biol; 2015 Apr; 41(4):944-51. PubMed ID: 25701530
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium-Enhanced MRI Features With Proposal of a Diagnostic Algorithm.
Tse JR; Felker ER; Cao JJ; Naini BV; Liang T; Lu DSK; Raman SS
AJR Am J Roentgenol; 2023 Apr; 220(4):539-550. PubMed ID: 36169546
[No Abstract] [Full Text] [Related]
8. Behavior of hepatocellular adenoma on real-time low-mechanical index contrast-enhanced ultrasonography with a second-generation contrast agent.
Ricci P; Cantisani V; D'Onofrio M; Sahani D; Pagliara E; Calliada F; Mehmet E; Sanjeva K; Faccioli N; Pozzi-Mucelli R; D'Ambrosio U; Passariello R
J Ultrasound Med; 2008 Dec; 27(12):1719-26. PubMed ID: 19022997
[TBL] [Abstract][Full Text] [Related]
9. Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked β-catenin activation in hepatocellular adenoma.
Reizine E; Ronot M; Ghosn M; Calderaro J; Frulio N; Bioulac-Sage P; Trillaud H; Vilgrain V; Paradis V; Luciani A
Eur Radiol; 2021 May; 31(5):3417-3426. PubMed ID: 33146794
[TBL] [Abstract][Full Text] [Related]
10. MR imaging of hepatocellular adenomas on genotype-phenotype classification: A report from China.
Wang H; Yang C; Rao S; Ji Y; Han J; Sheng R; Zeng M
Eur J Radiol; 2018 Mar; 100():135-141. PubMed ID: 29496071
[TBL] [Abstract][Full Text] [Related]
11. Hepatic Adenoma Subtypes on Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: Systematic Review and Meta-Analysis.
Kim TH; Woo S; Ebrahimzadeh S; McInnes MDF; Gerst SR; Do RK
AJR Am J Roentgenol; 2023 Jan; 220(1):28-38. PubMed ID: 35920706
[No Abstract] [Full Text] [Related]
12. New MRI features improve subtype classification of hepatocellular adenoma.
Bise S; Frulio N; Hocquelet A; Alberti N; Blanc JF; Laurent C; Laumonier H; Balabaud C; Bioulac-Sage P; Trillaud H
Eur Radiol; 2019 May; 29(5):2436-2447. PubMed ID: 30523457
[TBL] [Abstract][Full Text] [Related]
13. A Model-Based Prediction of the Probability of Hepatocellular Adenoma and Focal Nodular Hyperplasia Based on Characteristics on Contrast-Enhanced Ultrasound.
Taimr P; Bröker MEE; Dwarkasing RS; Hansen BE; de Knegt RJ; De Man RA; IJzermans JNM
Ultrasound Med Biol; 2017 Oct; 43(10):2144-2150. PubMed ID: 28743375
[TBL] [Abstract][Full Text] [Related]
14. Liver contrast-enhanced sonography: computer-assisted differentiation between focal nodular hyperplasia and inflammatory hepatocellular adenoma by reference to microbubble transport patterns.
Denis de Senneville B; Frulio N; Laumonier H; Salut C; Lafitte L; Trillaud H
Eur Radiol; 2020 May; 30(5):2995-3003. PubMed ID: 32002637
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of color parametric imaging and contrast-enhanced ultrasound in the differentiation of hepatocellular adenoma and well-differentiated hepatocellular carcinoma.
Liu YH; Fan ZH; Yin SS; Yan K; Sun LQ; Jiang BB
J Clin Ultrasound; 2022 Feb; 50(2):216-221. PubMed ID: 35084048
[TBL] [Abstract][Full Text] [Related]
16. Performance of Contrast-Enhanced Sonography Versus MRI With a Liver-Specific Contrast Agent for Diagnosis of Hepatocellular Adenoma and Focal Nodular Hyperplasia.
Bröker MEE; Taimr P; de Vries M; Braun LMM; de Man RA; Ijzermans JNM; Dwarkasing RS
AJR Am J Roentgenol; 2020 Jan; 214(1):81-89. PubMed ID: 31573852
[No Abstract] [Full Text] [Related]
17. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification.
Laumonier H; Bioulac-Sage P; Laurent C; Zucman-Rossi J; Balabaud C; Trillaud H
Hepatology; 2008 Sep; 48(3):808-18. PubMed ID: 18688875
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of focal nodular hyperplasia from hepatocellular adenomas with low-mechanical-index contrast-enhanced sonography (CEUS): effect of size on diagnostic confidence.
Roche V; Pigneur F; Tselikas L; Roux M; Baranes L; Djabbari M; Costentin C; Calderaro J; Laurent A; Rahmouni A; Luciani A
Eur Radiol; 2015 Jan; 25(1):186-95. PubMed ID: 25120205
[TBL] [Abstract][Full Text] [Related]
19. Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up.
Vernuccio F; Ronot M; Dioguardi Burgio M; Cauchy F; Choudhury KR; Dokmak S; Soubrane O; Valla D; Zucman-Rossi J; Paradis V; Vilgrain V
Radiology; 2020 May; 295(2):361-372. PubMed ID: 32181728
[TBL] [Abstract][Full Text] [Related]
20. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
Reizine E; Amaddeo G; Pigneur F; Baranes L; Legou F; Mulé S; Zegai B; Roche V; Laurent A; Rahmouni A; Calderaro J; Luciani A
Eur Radiol; 2018 Oct; 28(10):4243-4253. PubMed ID: 29721686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
